Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30th, 2026

Date: November 06, 2026 Listing Compliance Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001 Stock Code: 542248 Subject: Board Meeting Intimation in terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Notice is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India — (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, 13th November 2026, inter alia, to consider and approve, the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30th, 2026. Further, in accordance with the Company’s Code of Conduct for Prevention of Insider Trading, the Company has intimated vide letter dated September 25, 2026, that the trading window for dealing in the securities of the Company is already closed for the Designated Persons & its immediate relatives and Insiders of the Company since October 01, 2026 and the same shall open 48 hours after declaration of Financial Results of the company. Kindly take the above information on your records. Thanking You Your Faithfully, For Deccan Health Care Limited Shikha Das Company Secretary & Compliance Officer M. No A78917 Registered Office: Innovation Hub & Manufacturing: 6-3-347/17/5/A/Back Position, Plot No.13, Sector 03, IIE Pant Nagar, Dwarakapuri Colony, Punjagutta, SIDCUL, Udham Singh Nagar – 263153, Hyderabad – 500082, Telangana, India Uttarakhand, India Email: info@deccanhealthcare.co.in CIN: L72200TG1996PLC024351 Tel: +91 40 4709 6427 www.deccanhealthcare.co.in